Skip to search formSkip to main contentSkip to account menu

bevantolol

Known as: Bevantololum, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)- 3-(3-methylphenoxy)-2-propanol, 1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe pharmacokinetics of the new beta-adrenoceptor blocking drug bevantolol and some aspects of its beta-blocking effect… 
2004
2004
SummarySeven asthmatic patients were given a single placebo tablet in a first test session and then in two subsequent double… 
1994
1994
A direct, isocratic and simple chromatographic method is described for the enantiomeric separation of bevantolol (BEV) using… 
1986
1986
Double-blind and long-term open-label studies have demonstrated a remark ably favorable safety profile for bevantolol. The drug… 
1986
1986
The pharmacokinetic handling of the β, selective adrenoceptor blocking drug, bevantolol, was studied in 12 healthy volunteers… 
1985
1985
: The added hypotensive effect of bevantolol, a new cardioselective beta-blocker, was studied in 244 patients with mild to… 
1980
1979
1979
The effect of a new cardioselective beta adrenergic antagonist, bevantolol (CI-775), on regional myocardial blood flow and… 
1978
1978
The effect of coronary artery occlusion on endogenous triglycerides of left ventricular subepicardium and subendocardium was…